Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
British Journal of Haematology|August 24, 2006
Inherited and de novo von Willebrand disease 'Vicenza' in UK families with the R1205H mutation: diagnostic pitfalls and new insightsWilliam A Lester, Andrea M Guilliatt, Gurcharan K Surdhar, et al.
The Journal of Biological Chemistry|January 12, 2010
Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generationChristopher P Thomas, Lloyd T Morgan, Benjamin H Maskrey, et al.
Research and Practice in Thrombosis and Haemostasis|October 6, 2025
Emicizumab utilization, safety, and outcomes in people with severe hemophilia and no inhibitors: 3-year follow-up. A report from the UK Haemophilia Centre Doctors' OrganisationCaroline Wall, Hua Xiang, Ben Palmer, et al.
Blood|January 11, 2013
Both TMEM16F-dependent and TMEM16F-independent pathways contribute to phosphatidylserine exposure in platelet apoptosis and platelet activationRoger van Kruchten, Nadine J A Mattheij, Christine Saunders, et al.
European Journal of Haematology|July 11, 2012
History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophiliaDietje E Fransen van de Putte, Kathelijn Fischer, Michael Makris, et al.
Blood Advances|December 8, 2021
Reduced cardiovascular morbidity in patients with hemophilia: results of a 5-year multinational prospective studyPaul Van Der Valk, Michael Makris, Kathelijn Fischer, et al.
Thrombosis and Haemostasis|September 8, 2012
Increased prevalence of hypertension in haemophilia patientsDietje E Fransen van de Putte, Kathelijn Fischer, Michael Makris, et al.
Thrombosis and Haemostasis|November 10, 2012
Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patientsDietje E Fransen van de Putte, Kathelijn Fischer, Michael Makris, et al.
Blood|September 28, 2014
Recombinant long-acting glycoPEGylated factor IX in hemophilia B: a multinational randomized phase 3 trialPeter W Collins, Guy Young, Karin Knobe, et al.
Plos One|October 8, 2020
The procoagulant activity of tissue factor expressed on fibroblasts is increased by tissue factor-negative extracellular vesiclesMarcela Rosas, David A Slatter, Samya G Obaji, et al.
Pageof 9